Recurrent aphthous stomatitis (episodic mouth ulcers)
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
all patients
change toothpaste and avoid triggers
Patients should be advised to change their toothpaste to a sodium lauryl sulfate (SLS)-free formulation. An increased frequency of recurrent aphthous stomatitis (RAS) related to SLS-containing dentifrice has been reported, although other studies found no such association.[21]Healy CM, Paterson M, Joyston-Bechal S, et al. The effect of a sodium lauryl sulfate-free dentifrice on patients with recurrent oral ulceration. Oral Dis. 1999 Jan;5(1):39-43. http://www.ncbi.nlm.nih.gov/pubmed/10218040?tool=bestpractice.com However, because SLS dentifrices are in widespread use, it seems unlikely that this agent truly predisposes to, or causes, most RAS.[6]Jurge S, Kuffer R, Scully C, et al. Mucosal disease series. Number VI. Recurrent aphthous stomatitis. Oral Dis. 2006 Jan;12(1):1-21. http://www.ncbi.nlm.nih.gov/pubmed/16390463?tool=bestpractice.com
Patients should also be instructed to avoid recognized trigger foods, and acidic foods and drinks.[1]Scully C. Clinical practice. Aphthous ulceration. N Engl J Med. 2006 Jul 13;355(2):165-72. http://www.ncbi.nlm.nih.gov/pubmed/16837680?tool=bestpractice.com
For all patients, the possibility of local trauma (e.g., from sharp and/or broken teeth, dentures and orthodontic appliances, and biting during chewing) should be assessed, and appropriate dental treatment undertaken.[3]Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of recurrent aphthous stomatitis: a consensus approach. J Am Dent Assoc. 2003 Feb;134(2):200-7. http://www.ncbi.nlm.nih.gov/pubmed/12636124?tool=bestpractice.com
symptom relief
Treatment recommended for ALL patients in selected patient group
Topical therapies for symptom relief may be of benefit. These include topical anesthetics (e.g., lidocaine) and over-the-counter topical anti-inflammatory agents.[65]Matthews RW, Scully CM, Levers BG, et al. Clinical evaluation of benzydamine, chlorhexidine, and placebo mouthwashes in the management of recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol. 1987 Feb;63(2):189-91. http://www.ncbi.nlm.nih.gov/pubmed/3469601?tool=bestpractice.com
Primary options
lidocaine oropharyngeal viscous solution: (2%) children: 1.25 mL every 3 hours when required (swish around in mouth and spit out), maximum 4 doses/12 hours; adults: 15 mL every 3 hours when required (swish around in mouth and spit out), maximum 8 doses/day
antibacterial mouthwash
Treatment recommended for SOME patients in selected patient group
Adjunctive antimicrobial agents may also be of some value, in part by reducing secondary infection. These may reduce the severity and pain of ulceration.[3]Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of recurrent aphthous stomatitis: a consensus approach. J Am Dent Assoc. 2003 Feb;134(2):200-7. http://www.ncbi.nlm.nih.gov/pubmed/12636124?tool=bestpractice.com
Randomized controlled trials have shown that chlorhexidine oral solution can reduce the duration of recurrent aphthous stomatitis and increase the number of ulcer-free days.[51]Addy M, Tapper-Jones L, Seal M. Trial of astringent and antibacterial mouthwashes in the management of recurrent aphthous ulceration. Br Dent J. 1974 Jun 4;136(11):452-5. http://www.ncbi.nlm.nih.gov/pubmed/4531936?tool=bestpractice.com [52]Addy M, Carpenter R, Roberts WR. Management of recurrent aphthous ulceration: a trial of chlorhexidine gluconate gel. Br Dent J. 1976 Aug 17;141(4):118-20. http://www.ncbi.nlm.nih.gov/pubmed/786339?tool=bestpractice.com [53]Addy M. Hibitane in the treatment of aphthous ulceration. J Clin Periodontol. 1977 Dec;4(5):108-16. http://www.ncbi.nlm.nih.gov/pubmed/350904?tool=bestpractice.com [54]Hunter L, Addy M. Chlorhexidine gluconate mouthwash in the management of minor aphthous ulceration: a double-blind, placebo controlled cross-over trial. Br Dent J. 1987 Feb 7;162(3):106-10. http://www.ncbi.nlm.nih.gov/pubmed/3545267?tool=bestpractice.com
Topical tetracyclines used as rinses may also be effective.[55]Graykowski EA, Kingman A. Double-blind trial of tetracycline in recurrent aphthous ulceration. J Oral Pathol. 1978;7(6):376-82. http://www.ncbi.nlm.nih.gov/pubmed/105096?tool=bestpractice.com [56]Häyrinen-Immonen R, Sorsa T, Pettila J, et al. Effect of tetracyclines on collagenase activity in patients with recurrent aphthous ulcers. J Oral Pathol Med. 1994 Jul;23(6):269-72. http://www.ncbi.nlm.nih.gov/pubmed/7932246?tool=bestpractice.com These formulations need to be specially compounded. They may provide relief and reduce ulcer duration. Should be avoided in children less than 8 years of age as they may cause tooth discoloration and tooth staining. Patients should be advised to thoroughly brush teeth before use (as it stains the plaque on the teeth), and that it is not for regular long-term use.
Primary options
chlorhexidine oropharyngeal: (0.12%) children and adults: 10-15 mL as a mouthwash twice daily
oral vitamin B12
Treatment recommended for SOME patients in selected patient group
There is some evidence of benefit from vitamin B12, even in the absence of any deficiency; supplementation with oral vitamin B12 (cyanocobalamin) has been shown to be effective in studies, irrespective of serum B12 levels.[46]Volkov I, Rudoy I, Freud T, et al. Effectiveness of vitamin B12 in treating recurrent aphthous stomatitis: a randomized, double-blind, placebo-controlled trial. J Am Board Fam Med. 2009 Jan-Feb;22(1):9-16. https://www.jabfm.org/content/22/1/9 http://www.ncbi.nlm.nih.gov/pubmed/19124628?tool=bestpractice.com [47]Gulcan E, Toker S, Hatipoğlu H, et al. Cyanocobalamin may be beneficial in the treatment of recurrent aphthous ulcers even when vitamin B12 levels are normal. Am J Med Sci. 2008 Nov;336(5):379-82. http://www.ncbi.nlm.nih.gov/pubmed/19011392?tool=bestpractice.com [48]Liu HL, Chiu S, Chen KH. Effectiveness of vitamin B12 on recurrent aphthous stomatitis in long term care: a systematic review. JBI Database System Rev Implement Rep. 2013 Feb;11(2):281-307. https://journals.lww.com/jbisrir/Abstract/2013/11020/Effectiveness_of_Vitamin_B12_on_Recurrent_Aphthous.3.aspx
Primary options
cyanocobalamin (vitamin B12): children: consult specialist for guidance on dose; adults: 1000 micrograms orally once daily
More cyanocobalamin (vitamin B12)If available, sublingual tablets may be used; they should be dissolved under the tongue and swallowed.
oral iron
Treatment recommended for SOME patients in selected patient group
Iron supplementation in adults and children may be necessary to prevent ulcers that are a result of iron deficiency anemia. Initial treatment is daily oral iron replacement therapy.[49]Sumathi K, Shanthi B, Subha Palaneeswari M, et al. Significance of ferritin in recurrent oral ulceration. J Clin Diagn Res. 2014 Mar;8(3):14-5. https://www.jcdr.net/article_fulltext.asp?issn=0973-709x&year=2014&volume=8&issue=3&page=14&issn=0973-709x&id=4091 http://www.ncbi.nlm.nih.gov/pubmed/24783067?tool=bestpractice.com
Primary options
ferrous sulfate: children: 3 mg/kg orally once daily; adults: 65-130 mg orally once daily
More ferrous sulfateDose expressed as elemental iron. Alternative dose regimens may be available.
OR
ferrous gluconate: children: 3 mg/kg orally once daily; adults: 65-130 mg orally once daily
More ferrous gluconateDose expressed as elemental iron. Alternative dose regimens may be available.
OR
ferrous fumarate: children: 3 mg/kg orally once daily; adults: 65-130 mg orally once daily
More ferrous fumarateDose expressed as elemental iron. Alternative dose regimens may be available.
OR
ferric maltol: adults: 30 mg orally twice daily
topical corticosteroid
Topical corticosteroids are the mainstay of treatment if simple measures alone do not work.
A variety of different agents can be used, including a corticosteroid paste (a combination of a potent topical corticosteroid, such as triamcinolone, and dental paste), hydrocortisone buccal tablets, and betamethasone soluble tablets.[3]Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of recurrent aphthous stomatitis: a consensus approach. J Am Dent Assoc. 2003 Feb;134(2):200-7. http://www.ncbi.nlm.nih.gov/pubmed/12636124?tool=bestpractice.com However, these specific formulations of hydrocortisone and betamethasone are not available in the US and corticosteroid mouth rinses may need to be specially compounded.
A more potent topical corticosteroid, such as betamethasone dipropionate, clobetasol, or fluocinonide, may also be used.[3]Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of recurrent aphthous stomatitis: a consensus approach. J Am Dent Assoc. 2003 Feb;134(2):200-7. http://www.ncbi.nlm.nih.gov/pubmed/12636124?tool=bestpractice.com However, these drugs may need to be specially compounded in dental paste if they are not commercially available.
Treatment duration is case-dependent but there is no evidence of adrenal suppression with low-potency corticosteroids.
There are a limited number of topical corticosteroids that are licensed for oral use in children. If topical corticosteroids are needed, they can be used off-label, but only in children who can follow instructions with regards to spitting out the medication. This means that they usually cannot be used in children under 6 years of age. These treatments should only be started under specialist care after the child has been assessed and other causes of oral ulcers have been excluded.[64]Crighton AJ. Oral medicine in children. Br Dent J. 2017 Dec;223(9):706-12. http://www.ncbi.nlm.nih.gov/pubmed/29097798?tool=bestpractice.com
Primary options
triamcinolone topical: (0.1% paste) children: consult specialist for guidance on dose; adults: apply to the affected area(s) two to three times daily
symptom relief
Treatment recommended for ALL patients in selected patient group
Topical therapies for symptom relief may be of benefit. These include topical anesthetics (e.g., lidocaine) and over-the-counter topical anti-inflammatory agents.[65]Matthews RW, Scully CM, Levers BG, et al. Clinical evaluation of benzydamine, chlorhexidine, and placebo mouthwashes in the management of recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol. 1987 Feb;63(2):189-91. http://www.ncbi.nlm.nih.gov/pubmed/3469601?tool=bestpractice.com
Primary options
lidocaine oropharyngeal viscous solution: (2%) children: 1.25 mL every 3 hours when required (swish around in mouth and spit out), maximum 4 doses/12 hours; adults: 15 mL every 3 hours when required (swish around in mouth and spit out), maximum 8 doses/day
antibacterial mouthwash
Treatment recommended for SOME patients in selected patient group
Adjunctive antimicrobial agents may also be of some value, in part by reducing secondary infection. These may reduce the severity and pain of ulceration.[3]Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of recurrent aphthous stomatitis: a consensus approach. J Am Dent Assoc. 2003 Feb;134(2):200-7. http://www.ncbi.nlm.nih.gov/pubmed/12636124?tool=bestpractice.com
Randomized controlled trials have shown that chlorhexidine oral solution can reduce the duration of recurrent aphthous stomatitis and increase the number of ulcer-free days.[51]Addy M, Tapper-Jones L, Seal M. Trial of astringent and antibacterial mouthwashes in the management of recurrent aphthous ulceration. Br Dent J. 1974 Jun 4;136(11):452-5. http://www.ncbi.nlm.nih.gov/pubmed/4531936?tool=bestpractice.com [52]Addy M, Carpenter R, Roberts WR. Management of recurrent aphthous ulceration: a trial of chlorhexidine gluconate gel. Br Dent J. 1976 Aug 17;141(4):118-20. http://www.ncbi.nlm.nih.gov/pubmed/786339?tool=bestpractice.com [53]Addy M. Hibitane in the treatment of aphthous ulceration. J Clin Periodontol. 1977 Dec;4(5):108-16. http://www.ncbi.nlm.nih.gov/pubmed/350904?tool=bestpractice.com [54]Hunter L, Addy M. Chlorhexidine gluconate mouthwash in the management of minor aphthous ulceration: a double-blind, placebo controlled cross-over trial. Br Dent J. 1987 Feb 7;162(3):106-10. http://www.ncbi.nlm.nih.gov/pubmed/3545267?tool=bestpractice.com
Topical tetracyclines used as rinses may also be effective.[55]Graykowski EA, Kingman A. Double-blind trial of tetracycline in recurrent aphthous ulceration. J Oral Pathol. 1978;7(6):376-82. http://www.ncbi.nlm.nih.gov/pubmed/105096?tool=bestpractice.com [56]Häyrinen-Immonen R, Sorsa T, Pettila J, et al. Effect of tetracyclines on collagenase activity in patients with recurrent aphthous ulcers. J Oral Pathol Med. 1994 Jul;23(6):269-72. http://www.ncbi.nlm.nih.gov/pubmed/7932246?tool=bestpractice.com These formulations need to be specially compounded. They may provide relief and reduce ulcer duration. Should be avoided in children less than 8 years of age as they may cause tooth discoloration.
Primary options
chlorhexidine oropharyngeal: (0.12%) children and adults: 10-15 mL as a mouthwash twice daily
oral vitamin B12
Treatment recommended for SOME patients in selected patient group
There is some evidence of benefit from vitamin B12, even in the absence of any deficiency; supplementation with oral vitamin B12 (cyanocobalamin) has been shown to be effective in studies, irrespective of serum B12 levels.[46]Volkov I, Rudoy I, Freud T, et al. Effectiveness of vitamin B12 in treating recurrent aphthous stomatitis: a randomized, double-blind, placebo-controlled trial. J Am Board Fam Med. 2009 Jan-Feb;22(1):9-16. https://www.jabfm.org/content/22/1/9 http://www.ncbi.nlm.nih.gov/pubmed/19124628?tool=bestpractice.com [47]Gulcan E, Toker S, Hatipoğlu H, et al. Cyanocobalamin may be beneficial in the treatment of recurrent aphthous ulcers even when vitamin B12 levels are normal. Am J Med Sci. 2008 Nov;336(5):379-82. http://www.ncbi.nlm.nih.gov/pubmed/19011392?tool=bestpractice.com [48]Liu HL, Chiu S, Chen KH. Effectiveness of vitamin B12 on recurrent aphthous stomatitis in long term care: a systematic review. JBI Database System Rev Implement Rep. 2013 Feb;11(2):281-307. https://journals.lww.com/jbisrir/Abstract/2013/11020/Effectiveness_of_Vitamin_B12_on_Recurrent_Aphthous.3.aspx
Primary options
cyanocobalamin (vitamin B12): children: consult specialist for guidance on dose; adults: 1000 micrograms orally once daily
More cyanocobalamin (vitamin B12)If available, sublingual tablets may be used; they should be dissolved under the tongue and swallowed.
oral iron
Treatment recommended for SOME patients in selected patient group
Iron supplementation in adults and children may be necessary to prevent ulcers that are a result of iron deficiency anemia. Initial treatment is daily oral iron replacement therapy.[49]Sumathi K, Shanthi B, Subha Palaneeswari M, et al. Significance of ferritin in recurrent oral ulceration. J Clin Diagn Res. 2014 Mar;8(3):14-5. https://www.jcdr.net/article_fulltext.asp?issn=0973-709x&year=2014&volume=8&issue=3&page=14&issn=0973-709x&id=4091 http://www.ncbi.nlm.nih.gov/pubmed/24783067?tool=bestpractice.com
Primary options
ferrous sulfate: children: 3 mg/kg orally once daily; adults: 65-130 mg orally once daily
More ferrous sulfateDose expressed as elemental iron. Alternative dose regimens may be available.
OR
ferrous gluconate: children: 3 mg/kg orally once daily; adults: 65-130 mg orally once daily
More ferrous gluconateDose expressed as elemental iron. Alternative dose regimens may be available.
OR
ferrous fumarate: children: 3 mg/kg orally once daily; adults: 65-130 mg orally once daily
More ferrous fumarateDose expressed as elemental iron. Alternative dose regimens may be available.
OR
ferric maltol: adults: 30 mg orally twice daily
systemic corticosteroid or colchicine
If recurrent aphthous stomatitis (RAS) fails to respond to topical therapies, systemic therapies may be required.
Oral prednisone as a 1-week course tapered over a second week is one suggested regimen.[3]Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of recurrent aphthous stomatitis: a consensus approach. J Am Dent Assoc. 2003 Feb;134(2):200-7. http://www.ncbi.nlm.nih.gov/pubmed/12636124?tool=bestpractice.com
The first-line systemic immunomodulator used in RAS and the mucocutaneous manifestations of Behcet syndrome is colchicine.[61]Taylor J, Glenny AM, Walsh T, et al. Interventions for managing oral ulcers in Behçet's disease. Cochrane Database Syst Rev. 2014 Sep 25;(9):CD011018. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011018.pub2/full http://www.ncbi.nlm.nih.gov/pubmed/25254615?tool=bestpractice.com
Systemic treatments for RAS are rarely used in children under the age of 12 years, and are only commenced under specialist care. Colchicine is rarely used in children.
Primary options
prednisone: children: 0.5 to 1 mg/kg/day orally for 7 days, then taper over 7 days; adults: 30-60 mg orally once daily for 7 days, then taper over 7 days
Secondary options
colchicine: adults: 0.5 mg orally two to three times daily
symptom relief
Treatment recommended for ALL patients in selected patient group
Topical therapies for symptom relief may be of benefit. These include topical anesthetics (e.g., lidocaine) and over-the-counter topical anti-inflammatory agents.[65]Matthews RW, Scully CM, Levers BG, et al. Clinical evaluation of benzydamine, chlorhexidine, and placebo mouthwashes in the management of recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol. 1987 Feb;63(2):189-91. http://www.ncbi.nlm.nih.gov/pubmed/3469601?tool=bestpractice.com
Primary options
lidocaine oropharyngeal viscous solution: (2%) children: 1.25 mL every 3 hours when required (swish around in mouth and spit out), maximum 4 doses/12 hours; adults: 15 mL every 3 hours when required (swish around in mouth and spit out), maximum 8 doses/day
antibacterial mouthwash
Treatment recommended for SOME patients in selected patient group
Adjunctive antimicrobial agents may also be of some value, in part by reducing secondary infection. These may reduce the severity and pain of ulceration.[3]Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of recurrent aphthous stomatitis: a consensus approach. J Am Dent Assoc. 2003 Feb;134(2):200-7. http://www.ncbi.nlm.nih.gov/pubmed/12636124?tool=bestpractice.com
Randomized controlled trials have shown that chlorhexidine oral solution can reduce the duration of recurrent aphthous stomatitis and increase the number of ulcer-free days.[51]Addy M, Tapper-Jones L, Seal M. Trial of astringent and antibacterial mouthwashes in the management of recurrent aphthous ulceration. Br Dent J. 1974 Jun 4;136(11):452-5. http://www.ncbi.nlm.nih.gov/pubmed/4531936?tool=bestpractice.com [52]Addy M, Carpenter R, Roberts WR. Management of recurrent aphthous ulceration: a trial of chlorhexidine gluconate gel. Br Dent J. 1976 Aug 17;141(4):118-20. http://www.ncbi.nlm.nih.gov/pubmed/786339?tool=bestpractice.com [53]Addy M. Hibitane in the treatment of aphthous ulceration. J Clin Periodontol. 1977 Dec;4(5):108-16. http://www.ncbi.nlm.nih.gov/pubmed/350904?tool=bestpractice.com [54]Hunter L, Addy M. Chlorhexidine gluconate mouthwash in the management of minor aphthous ulceration: a double-blind, placebo controlled cross-over trial. Br Dent J. 1987 Feb 7;162(3):106-10. http://www.ncbi.nlm.nih.gov/pubmed/3545267?tool=bestpractice.com
Topical tetracyclines used as rinses may also be effective.[55]Graykowski EA, Kingman A. Double-blind trial of tetracycline in recurrent aphthous ulceration. J Oral Pathol. 1978;7(6):376-82. http://www.ncbi.nlm.nih.gov/pubmed/105096?tool=bestpractice.com [56]Häyrinen-Immonen R, Sorsa T, Pettila J, et al. Effect of tetracyclines on collagenase activity in patients with recurrent aphthous ulcers. J Oral Pathol Med. 1994 Jul;23(6):269-72. http://www.ncbi.nlm.nih.gov/pubmed/7932246?tool=bestpractice.com These formulations need to be specially compounded. They may provide relief and reduce ulcer duration. Should be avoided in children less than 8 years of age as they may cause tooth discoloration.
Primary options
chlorhexidine oropharyngeal: (0.12%) children and adults: 10-15 mL as a mouthwash twice daily
oral vitamin B12
Treatment recommended for SOME patients in selected patient group
There is some evidence of benefit from vitamin B12, even in the absence of any deficiency; supplementation with oral vitamin B12 (cyanocobalamin) has been shown to be effective in studies, irrespective of serum B12 levels.[46]Volkov I, Rudoy I, Freud T, et al. Effectiveness of vitamin B12 in treating recurrent aphthous stomatitis: a randomized, double-blind, placebo-controlled trial. J Am Board Fam Med. 2009 Jan-Feb;22(1):9-16. https://www.jabfm.org/content/22/1/9 http://www.ncbi.nlm.nih.gov/pubmed/19124628?tool=bestpractice.com [47]Gulcan E, Toker S, Hatipoğlu H, et al. Cyanocobalamin may be beneficial in the treatment of recurrent aphthous ulcers even when vitamin B12 levels are normal. Am J Med Sci. 2008 Nov;336(5):379-82. http://www.ncbi.nlm.nih.gov/pubmed/19011392?tool=bestpractice.com [48]Liu HL, Chiu S, Chen KH. Effectiveness of vitamin B12 on recurrent aphthous stomatitis in long term care: a systematic review. JBI Database System Rev Implement Rep. 2013 Feb;11(2):281-307. https://journals.lww.com/jbisrir/Abstract/2013/11020/Effectiveness_of_Vitamin_B12_on_Recurrent_Aphthous.3.aspx
Primary options
cyanocobalamin (vitamin B12): children: consult specialist for guidance on dose; adults: 1000 micrograms orally once daily
More cyanocobalamin (vitamin B12)If available, sublingual tablets may be used; they should be dissolved under the tongue and swallowed.
oral iron
Treatment recommended for SOME patients in selected patient group
Iron supplementation in adults and children may be necessary to prevent ulcers that are a result of iron deficiency anemia. Initial treatment is daily oral iron replacement therapy.[49]Sumathi K, Shanthi B, Subha Palaneeswari M, et al. Significance of ferritin in recurrent oral ulceration. J Clin Diagn Res. 2014 Mar;8(3):14-5. https://www.jcdr.net/article_fulltext.asp?issn=0973-709x&year=2014&volume=8&issue=3&page=14&issn=0973-709x&id=4091 http://www.ncbi.nlm.nih.gov/pubmed/24783067?tool=bestpractice.com
Primary options
ferrous sulfate: children: 3 mg/kg orally once daily; adults: 65-130 mg orally once daily
More ferrous sulfateDose expressed as elemental iron. Alternative dose regimens may be available.
OR
ferrous gluconate: children: 3 mg/kg orally once daily; adults: 65-130 mg orally once daily
More ferrous gluconateDose expressed as elemental iron. Alternative dose regimens may be available.
OR
ferrous fumarate: children: 3 mg/kg orally once daily; adults: 65-130 mg orally once daily
More ferrous fumarateDose expressed as elemental iron. Alternative dose regimens may be available.
OR
ferric maltol: adults: 30 mg orally twice daily
specialist referral
The use of additional agents above systemic corticosteroids and colchicine are typically provided under specialist supervision. For example, the use of systemic immunomodulators or anti-inflammatory agents, such as azathioprine or thalidomide, may be considered following referral.[1]Scully C. Clinical practice. Aphthous ulceration. N Engl J Med. 2006 Jul 13;355(2):165-72. http://www.ncbi.nlm.nih.gov/pubmed/16837680?tool=bestpractice.com [3]Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of recurrent aphthous stomatitis: a consensus approach. J Am Dent Assoc. 2003 Feb;134(2):200-7. http://www.ncbi.nlm.nih.gov/pubmed/12636124?tool=bestpractice.com [45]Letsinger JA, McCarty MA, Jorizzo JL. Complex aphthosis: a large case series with evaluation algorithm and therapeutic ladder from topicals to thalidomide. J Am Acad Dermatol. 2005 Mar;52(3 Pt 1):500-8. http://www.ncbi.nlm.nih.gov/pubmed/15761429?tool=bestpractice.com [59]Hello M, Barbarot S, Bastuji-Garin S, et al. Use of thalidomide for severe recurrent aphthous stomatitis: a multicenter cohort analysis. Medicine (Baltimore). 2010 May;89(3):176-82. https://journals.lww.com/md-journal/Fulltext/2010/05000/Use_of_Thalidomide_for_Severe_Recurrent_Aphthous.5.aspx http://www.ncbi.nlm.nih.gov/pubmed/20453604?tool=bestpractice.com [60]Toader MP, Esanu IM, Taranu T, et al. Colchicine in the treatment of refractory aphthous ulcerations: review of the literature and two case reports. Exp Ther Med. 2021 Mar;21(3):281. https://www.spandidos-publications.com/10.3892/etm.2021.9712 http://www.ncbi.nlm.nih.gov/pubmed/33603888?tool=bestpractice.com There is weak evidence to support the use of azathioprine.
Thalidomide is rarely used, only prescribed by specialists with experience in its use, and would never be commenced in primary care - there may be tight legislation around the prescribing of it.
The use of thalidomide in RAS is supported by data both in RAS and in patients with aphthous-like ulceration in HIV infection.[62]Revuz J, Guillaume JC, Janier M, et al. Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis. Arch Dermatol. 1990 Jul;126(7):923-7. http://www.ncbi.nlm.nih.gov/pubmed/2193629?tool=bestpractice.com [63]Nicolau DP, West TE. Thalidomide: treatment of severe recurrent aphthous stomatitis in patients with AIDS. DICP. 1990 Nov;24(11):1054-6. http://www.ncbi.nlm.nih.gov/pubmed/2275226?tool=bestpractice.com In these patient groups, open and double-blind studies have shown that thalidomide is the most reliably effective agent available for the management of severe, refractory RAS.[6]Jurge S, Kuffer R, Scully C, et al. Mucosal disease series. Number VI. Recurrent aphthous stomatitis. Oral Dis. 2006 Jan;12(1):1-21. http://www.ncbi.nlm.nih.gov/pubmed/16390463?tool=bestpractice.com However, great caution is required for its use in patients with RAS and specialist referral is recommended.[1]Scully C. Clinical practice. Aphthous ulceration. N Engl J Med. 2006 Jul 13;355(2):165-72. http://www.ncbi.nlm.nih.gov/pubmed/16837680?tool=bestpractice.com [3]Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of recurrent aphthous stomatitis: a consensus approach. J Am Dent Assoc. 2003 Feb;134(2):200-7. http://www.ncbi.nlm.nih.gov/pubmed/12636124?tool=bestpractice.com Men and women require effective contraception during treatment and for 1 month before and 1 month after use of thalidomide.
Thalidomide is not used in children unless in exceptional circumstances and would only ever be instigated by a specialist team.
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer